Back to Search
Start Over
Takeda launches Vipidia (alogliptin) in the UK.
- Source :
- Diabetes Digest; 2014, Vol. 13 Issue 1, p38-38, 1/9p
- Publication Year :
- 2014
-
Abstract
- The article offers brief information on the launch of Vipidia as an inhibitor class of drugs designed as an add-on therapy for the treatment of type 2 diabetes in adults, from Takeda.
Details
- Language :
- English
- ISSN :
- 14745704
- Volume :
- 13
- Issue :
- 1
- Database :
- Complementary Index
- Journal :
- Diabetes Digest
- Publication Type :
- Periodical
- Accession number :
- 95108289